一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen(AKAO)$ EFFECT - Notice of Effectiveness Filed: 2019-08-20 AccNo: 9999999995-19-001929 Size: 1 KB 网页链接
$Achaogen(AKAO)$ EFFECT - Notice of Effectiveness Filed: 2019-08-20 AccNo: 9999999995-19-001930 Size: 1 KB 网页链接
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223513 Size: 21 KB 网页链接
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223516 Size: 21 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223522 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223523 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223527 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223530 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223534 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223540 Size: 24 KB 网页链接